Cargando…
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
BACKGROUND: Ameloblastomas are common benign epithelial odontogenic neoplasms that present an aggressive and unpredictable behavior that may modify treatment strategies. Different signaling pathways that participate in the progression of these tumors have been identified. B-raf proto-oncogene serine...
Autores principales: | González-González, Rogelio, López-Verdín, Sandra, Lavalle-Carrasco, Jesús, Molina-Frechero, Nelly, Isiordia-Espinoza, Mario, Carreón-Burciaga, Ramón G, Bologna-Molina, Ronell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935689/ https://www.ncbi.nlm.nih.gov/pubmed/31976308 http://dx.doi.org/10.5306/wjco.v11.i1.31 |
Ejemplares similares
-
Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
por: Carreón-Burciaga, Ramón G., et al.
Publicado: (2018) -
Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns
por: Carreón-Burciaga, Ramón Gil, et al.
Publicado: (2015) -
Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas
por: González-González, Rogelio, et al.
Publicado: (2016) -
Molecular markers of cell adhesion in ameloblastomas. An update
por: González-González, Rogelio, et al.
Publicado: (2014) -
Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review
por: López-Verdín, Sandra, et al.
Publicado: (2018)